| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
apolipoprotein H | 0.563 | 0.769 | 1.6E-15 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
Alu-mediated CDKN1A/p21 transcriptional regulator | 0.931 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
Rho GTPase activating protein 15 | 0.682 | 0.462 | 1.4E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
Rho GTPase activating protein 23 | 0.931 | 0.115 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
Rho GTPase activating protein 26 | 0.656 | 0.500 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ariadne RBR E3 ubiquitin protein ligase 2 | 0.792 | 0.269 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
ARVCF delta catenin family member | 0.540 | 0.769 | 5.0E-11 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ankyrin repeat and SOCS box containing 2 | 0.769 | 0.308 | 6.8E-15 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
activating transcription factor 3 | 0.494 | 0.885 | 8.9E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
activating transcription factor 7 interacting protein | 0.543 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
autophagy related 14 | 0.760 | 0.423 | 0.17 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
autophagy related 5 | 0.462 | 0.885 | 0.98 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 | 0.617 | 0.577 | 2.2E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ATPase phospholipid transporting 9A (putative) | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||||
|
ataxin 1 | 0.534 | 0.769 | 0.97 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
ataxin 2 | 0.482 | 0.808 | 0.85 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2009 | 2019 | ||||||||
|
ataxin 7 like 1 | 0.890 | 0.154 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
AU RNA binding methylglutaconyl-CoA hydratase | 0.686 | 0.346 | 8.0E-06 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
antizyme inhibitor 1 | 0.716 | 0.462 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
BTB domain and CNC homolog 2 | 0.539 | 0.731 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 4 | 2016 | 2019 | ||||||||
|
BAH domain and coiled-coil containing 1 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||||
|
BCL2 antagonist/killer 1 | 0.555 | 0.769 | 7.4E-06 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 |